Related Experiment Videos
Somatostatin and the endocrine pancreas
Current Topics in Molecular Endocrinology
|January 1, 1976
Summary
Somatostatin, a pancreatic hormone, is being explored for diabetes and islet tumor treatments. Further research aims to develop longer-acting analogs and understand its role in regulating insulin and glucagon secretion.
Area of Science:
- Endocrinology
- Molecular Biology
- Cell Biology
Background:
- Somatostatin is utilized as a research tool to study pancreatic alpha- and beta- cell functions.
- Its inhibitory effect on insulin and glucagon secretion suggests therapeutic potential.
Purpose of the Study:
- To explore therapeutic applications of somatostatin, including diabetes mellitus treatment and palliative care for inoperable islet tumors.
- To develop more specific somatostatin analogs with extended duration for clinical evaluation.
- To investigate the potential role of somatostatin as a local regulator of insulin and glucagon release within pancreatic D cells.
Main Methods:
- Research utilizing somatostatin as a tool to investigate pancreatic cell function.
- Development of novel somatostatin analogs.
- Studies on factors governing somatostatin secretion and its mechanism of action.
Main Results:
- Somatostatin's ability to inhibit insulin and glucagon secretion has been established.
- Ongoing experiments focus on creating improved analogs for clinical assessment.
- The localization of somatostatin in pancreatic D cells suggests a paracrine regulatory role.
Conclusions:
- Somatostatin holds promise for therapeutic interventions in diabetes and islet cell tumors.
- Further research is crucial to elucidate somatostatin secretion regulation and action.
- D-cell dysfunction may lead to novel clinical syndromes.